StockData
Acumen Pharmaceuticals, Inc. logo

Acumen Pharmaceuticals, Inc. (ABOS) income statement

ABOSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 2/30
$0.19−0.01 (-3.52%)

Close on Nov 20, 2026Market cap $13.49MP/E –Yield –

Acumen Pharmaceuticals, Inc. financial ratios

See a number that looks wrong?